首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Obesity pillars

缩写:

ISSN:

e-ISSN:2667-3681

IF/分区:5.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引257
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jennifer L Warnick,Katherine E Darling,Smriti Maskey et al. Jennifer L Warnick et al.
Background: The prevalence of obesity among youth with type 1 diabetes (T1D) has significantly increased over the past few decades, leading to increased risks for morbidity and early mortality. Despite this growing need, ...
Jessica Duncan,Patrick Lee Stevens,Emily Bigby et al. Jessica Duncan et al.
Background: Here we show results of 1,131 patients on therapy with semaglutide who underwent a comprehensive clinical protocol utilizing the Individualized Virtual Integrative Medicine (IVIM) approach, evaluating the prot...
Alvin Mondoh,Hilary Craig,Michael Crotty et al. Alvin Mondoh et al.
Introduction: The rising prevalence of obesity is of particular concern due to its association with a range of serious complications, including type 2 diabetes mellitus, cardiovascular diseases, and certain types of cance...
Dariush Mozaffarian,Monica Agarwal,Monica Aggarwal et al. Dariush Mozaffarian et al.
Background: Glucagon-like peptide 1 receptor agonists and combination medications (GLP-1s) are shifting the treatment landscape for obesity. However, real-world challenges and limited clinician and public knowledge on nut...
Agete Tadewos Hirigo,Moges Derbe,Daniel Yilma et al. Agete Tadewos Hirigo et al.
Background: we aimed to evaluate the impact of lifestyle modification counselling on weight and body composition among adults with overweight or obesity receiving antiretroviral treatment (ART). ...
W Scott Butsch,Suela Sulo,Andrew T Chang et al. W Scott Butsch et al.
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) drug-induced weight loss is associated with fat mass reduction but can also lead to nutritional deficiencies and loss of muscle. We quantified nutritional d...
Alejandro Campos,Kathryn L Fantasia,Ivania Rizo Alejandro Campos
Background: Obesity is a highly prevalent, chronic, and treatable disease that disproportionately impacts some minoritized populations who seek care in safety-net settings. Given that primary care providers (PCPs) often s...
Nasheeta Peer,Janice Sewlall,Yusentha Balakrishna et al. Nasheeta Peer et al.
Aim: To describe the distribution of childhood obesity and their related comorbidities in
Ian J Neeland,Kostas Tsintzas,Bo Ahrén et al. Ian J Neeland et al.
Background: Premeal whey protein (WP) consumption may reduce postprandial glucose (PPG) levels and appetite. We assessed the effects of twice daily consumption of a low-dose non-gelling novel WP formulation (WP microgel [...
Florencia Ziemke,Soufiane Belarj,Jem Esguerra et al. Florencia Ziemke et al.
Background: Nausea is one of the most reported side effect of GLP-1 receptor agonists (GLP-1a). Current recommendations fall short in taming the symptoms, include antiemetic medication, behavior changes, GLP-1a dose adjus...